Cases & Deals

  • Home
  • Practices
  • Eli Lilly participates in £90 million ($114 million) Series A financing of Myricx

Share

Eli Lilly participates in £90 million ($114 million) Series A financing of Myricx

July 2024

Client(s) Eli Lilly and Company

Jones Day advised Eli Lilly and Company in connection with the £90 million ($114 million) Series A financing of Myricx, a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.